Delivery Order SPE2DB20D3303-SPE2DB23FA1QT

Award Date 9/21/23
Potential Completion Date 9/22/23
Potential Value $15
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed price delivery order valued at thirty-nine dollars and eighty cents to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection. As the prime contractor, Amerisourcebergen will supply 2mL vials of the drug to the DLA from its facility in Conshohocken, Pennsylvania over a one day period concluding on June 29, 2023. The delivery order was issued under an existing DLA pharmaceuticals contract vehicle but no further details were...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $208.01 to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection vials. As the prime contractor, Amerisourcebergen will supply the pharmaceutical product to the DLA under a one-day period of performance from July 13 to July 14, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform the contract from its location in Conshohocken,...
The Defense Logistics Agency awarded a $180,360 firm fixed price delivery order to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection, 5 mg/ml vials. The single day contract has a period of performance from July 19, 2023 through July 20, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order...
The Defense Logistics Agency awarded a $180,360 delivery order to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection. As the prime contractor, Amerisourcebergen will supply 5 mg/ml vials of the drug to the DLA for use by the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from August 4th through August 7th, 2023. The firm fixed price contract has no set aside designation....
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $39,800 to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection. The delivery order is for 2mL vials of the drug to be supplied from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 10, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor to fulfill this order for midazolam...
The Defense Logistics Agency awarded a $571 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 mg/2 ml vials of midazolam hydrochloride. As the prime contractor, Amerisourcebergen will supply the midazolam to the DLA under a one-day contract spanning September 5-6, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facility in Conshohocken, Pennsylvania to support the DLA's medical supply needs. No subcontractors or...
The Defense Logistics Agency awarded a $8,180 delivery order to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection. As the prime contractor, Amerisourcebergen will supply 5 mg/mL vials of the drug to fulfill requirements under the contract. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 9-10, 2023. The firm fixed price contract was issued under the DLA's pharmaceuticals and medical/surgical...
The Defense Logistics Agency awarded a $8,180 firm fixed price delivery order to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection. As part of its pharmaceutical supply chain management responsibilities for the Department of Defense, DLA issued the order against an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver vials of the drug to a location in Conshohocken, Pennsylvania by August 10, 2023 in support of DOD medical readiness programs. No...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred twenty thousand two hundred four dollars to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection. Performance will take place in Conshohocken, Pennsylvania under the prime contractor's parent company Amerisourcebergen Corporation. The single day order from July 17th to 18th, 2023 is associated with DLA's pharmaceutical procurement programs and supports the agency's mission to...
The Defense Logistics Agency awarded a $301 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 mg/2 ml vials of midazolam hydrochloride. As the prime contractor, Amerisourcebergen will deliver the midazolam to a facility in Conshohocken, Pennsylvania under a one-day period of performance from July 11-12, 2023. The Defense Logistics Agency utilizes midazolam and similar pharmaceuticals to support medical readiness across the Department of Defense. Amerisourcebergen, a...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB23FA1QT
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $15,030 to Amerisourcebergen Drug Corporation for midazolam hydrochloride injection vials. As the prime contractor, Amerisourcebergen will supply the pharmaceutical to the DLA under a one-day contract spanning September 21 to 22, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the order from its facility in Conshohocken, Pennsylvania. The delivery order was issued against an existing DLA indefinite-delivery/indefinite-quantity vehicle, though further details were not provided. No subcontractors or set-aside designations were indicated. The midazolam will support the DLA's mission to provide logistics support to the Department of Defense and other authorized customers.

Generated 12/21/23, 10:03 AM